Avastin Concentrate for Solution for Infusion 400mg/16ml
Product details
Registration number: SIN14097P
Classification: Prescription Only
Active ingredients: Bevacizumab
Strength: 400mg
Dosage form: INFUSION, SOLUTION CONCENTRATE
Route: INTRAVENOUS
Registrant: ROCHE SINGAPORE PTE. LTD.
ATC code: L01FG01
HSA approval date: 6 February 2012
Manufacturer(s):
- F. Hoffmann-La Roche AG
- Roche Diagnostics GmbH
- Genentech Inc., Hillsboro
Manufacturing country/countries: UNITED STATES; SWITZERLAND; GERMANY
What are the HSA registration number and classification for Avastin Concentrate for Solution for Infusion 400mg/16ml?
According to the HSA dataset updated 7 August 2026:
Registration number: SIN14097P
Classification: Prescription Only
What active ingredients and strength are recorded for Avastin Concentrate for Solution for Infusion 400mg/16ml?
According to the HSA dataset updated 7 August 2026:
Active ingredients: Bevacizumab
Strength: 400mg
Ingredients and strengths are listed separately as recorded by HSA; their positions do not establish a one-to-one match. This is not a dosing instruction.
What dosage form and route are recorded for Avastin Concentrate for Solution for Infusion 400mg/16ml?
According to the HSA dataset updated 7 August 2026:
Dosage form: INFUSION, SOLUTION CONCENTRATE
Route: INTRAVENOUS
Who is the recorded registrant for Avastin Concentrate for Solution for Infusion 400mg/16ml?
According to the HSA dataset updated 7 August 2026:
Registrant: ROCHE SINGAPORE PTE. LTD.
Which manufacturers and countries are listed for Avastin Concentrate for Solution for Infusion 400mg/16ml?
According to the HSA dataset updated 7 August 2026:
Manufacturer(s):
- F. Hoffmann-La Roche AG
- Roche Diagnostics GmbH
- Genentech Inc., Hillsboro
Manufacturing country/countries: UNITED STATES; SWITZERLAND; GERMANY
Where can I look up Avastin Concentrate for Solution for Infusion 400mg/16ml in the HSA register?
Open HSA’s therapeutic product register and search for registration number SIN14097P or the exact product name Avastin Concentrate for Solution for Infusion 400mg/16ml. The general register link does not preselect this product.
What are the source dates for this Avastin Concentrate for Solution for Infusion 400mg/16ml record?
This record is from HSA’s List of Registered Therapeutic Products on data.gov.sg. Dataset update: 7 August 2026. Retrieval date: 13 November 2026.
The dataset date is a snapshot date, not a separate current-register check for every product. Later direct checks are recorded separately.
Has this Avastin Concentrate for Solution for Infusion 400mg/16ml record had a separate HSA register check?
No separate current-register check is recorded for this product. Its presence in the imported dataset does not establish its current registration status.
Search the HSA register using SIN14097P for the latest record.
Sources and dates
HSA dataset: 2026. Updated: 13 November 2026.
Factual product information only; no dosing, treatment or suitability advice.
Updated and reviewed by: Dr Joel Lim MBChB UK (PG Dip Dermatology), Resident Physician.
.png)